Pharmaceutical Company To Pay $6M To End Kickback Claims In Marketing Plan
BOSTON — Pharmaceutical company Ultragenyx Pharmaceutical Inc. will pay $6 million to settle claims that it violated the False Claims Act (FCA) in its marketing efforts for its drug Crysvita, which...To view the full article, register now.
Already a subscriber? Click here to view full article